MDT launches MiniMed Go Smart MDI with the Simplera sensor in Europe, advancing connected insulin care as the Diabetes unit's IPO plans progress.
GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and ...
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that ...
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the ...
GALWAY, Ireland, Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated ...
Medtronic has earned FDA approval that will allow it to broaden the scope of its MiniMed 780G system portfolio. FDA has cleared Medtronic’s SmartGuard algorithm as an interoperable automated glycemic ...
Medtronic said the Food and Drug Administration has cleared its SmartGuard algorithm as an interoperable automated glycemic controller, enabling integration with the Instinct sensor, made by Abbott, ...
Add Yahoo as a preferred source to see more of our stories on Google. Medtronic has received 510(k) clearance for the use of its MiniMed 780G pump with two ultra-rapid-acting insulins and with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results